Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Michael Frank

32 indexed publications match this author name.

ORCID: 0000-0001-8449-237X
OpenAlex: https://openalex.org/A5033477592

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 12 Safety 9 Receptor Pharmacology 9 Healthy Volunteers 6 Clinical Trial 5 General 5 Addiction 5 Treatment-Resistant Depression 4 Pharmacology 4 Mechanism of Action 4 Review Article 3 Toxicity 3

Journals

Pharmacopsychiatry 3 ClinicalTrials.gov 2 Psychopharmacology 2 CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne 2 OSF 1 Gastrointestinal Endoscopy 1 Journal of Clinical Epidemiology 1 Current topics in behavioral neurosciences 1

Publication history

A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10 Psilocybin bei Depression: Systematisches Review und Meta-Analyse zur antidepressiven WirksamkeitOSF · 2026-07-10 Sa1731 A PILOT STUDY OF OPEN-LABEL PSILOCYBIN-ASSISTED THERAPY IN TREATMENT-REFRACTORY IBSGastrointestinal Endoscopy · 2026-05-01 Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybinJournal of Clinical Epidemiology · 2026-04-01 Classifying Psychedelic-Related Complications.Current topics in behavioral neurosciences · 2026-01-01 Psychedelic-assisted therapy: An overview for the internist.Cleveland Clinic journal of medicine · 2025-03-03 Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder.Psychedelics · 2025-01-01 Neural effects of psilocybin-treatment in patients with treatment-resistant depressionNeuroscience Applied · 2024-01-01 Is Poorly Assisted Psilocybin Treatment an Increasing Risk?The American journal of psychiatry · 2024-01-01 Mystical and Affective Aspects of Psychedelic Use in a Naturalistic Setting: A Linguistic Analysis of Online Experience Reports.Journal of psychoactive drugs · 2024-01-01 Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder.Journal of psychiatric research · 2023-05-01 The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24 347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic DisorderBiological Psychiatry · 2023-04-10 Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?Clinical Chemistry · 2023-03-07 Novel antidepressant drugs: Beyond monoamine targets.CNS spectrums · 2023-02-01 Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.Neuropharmacology · 2022-11-01 Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.Psychopharmacology · 2008-07-01 Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.Journal of psychopharmacology (Oxford, England) · 2007-05-01 Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.Pharmacopsychiatry · 2005-11-01 Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosisPharmacopsychiatry · 2005-09-01 Khat and mushrooms associated with psychosis.The world journal of biological psychiatry: the official journal of the World Federation of Societies of Biological Psychiatry · 2004-01-01 Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans.Neuropsychobiology · 2002-01-01 Nonmedical drug use among adolescent students: highlights from the 1999 Ontario Student Drug Use Survey.CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne · 2000-06-13 Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 1999-06-01 Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.Psychopharmacology · 1999-02-01 Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.Behavioural pharmacology · 1998-11-01 Recent findings from the Ontario Student Drug Use Survey.CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne · 1998-09-08 529 The hallucinogen psilocybin increases prepulse inhibition of the startle reflex in healthy humansInternational Journal of Psychophysiology · 1998-09-01 Methodological issues of human experimental research with hallucinogens.Pharmacopsychiatry · 1998-07-01 Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid-liquid extraction with automated on-line solid-phase extractionJournal of Chromatography B: Biomedical Sciences and Applications · 1998-05-01 Increased activation of indirect semantic associations under psilocybin.Biological psychiatry · 1996-06-15 Occurrence of psilocybin and psilocin in Psilocybe pseudobullacea (Petch) Pegler from the Venezuelan AndesJournal of Ethnopharmacology · 1994-07-01

Author directory